S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.51 (-2.10%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.51 (-2.10%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.51 (-2.10%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.51 (-2.10%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
Free Trial
ASX:ACL

Australian Clinical Labs (ACL) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free ACL Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
3.72%
Price Target
N/A
Stock Analysis
Stock Analysis
ACL stock logo

About Australian Clinical Labs Stock (ASX:ACL)

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.

ACL Stock News Headlines

April 18, 2024 | morningstar.com
Australian Clinical Labs Ltd
April 2, 2024 | au.news.yahoo.com
Truth Social made 1000 times less money than X last year
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
March 31, 2024 | sg.finance.yahoo.com
Is It Too Late To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?
March 27, 2024 | au.investing.com
ASX 200 adds 0.8% as S&P 500 resets record valuations
February 18, 2024 | au.lifestyle.yahoo.com
With Twilio under activist pressure, Segment could be put up for sale
February 16, 2024 | finance.yahoo.com
Is Australian Clinical Labs Limited's (ASX:ACL) Latest Stock Performance A Reflection Of Its Financial Health?
January 20, 2024 | uk.finance.yahoo.com
Is There An Opportunity With Australian Clinical Labs Limited's (ASX:ACL) 36% Undervaluation?
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
January 11, 2024 | afr.com
Why this fundie is backing ACL, Ramsay and Dexus
December 14, 2023 | msn.com
Healius shares tumble as Australian Clinical Labs intends to withdraw $1 billion offer
December 14, 2023 | msn.com
Australian Clinical Labs to withdraw $1 billion offer for Healius; stocks fall
December 14, 2023 | afr.com
ACL pulls Healius bid as ACCC blocks pathology shake-up
December 14, 2023 | news.yahoo.com
Australian regulator kills ACL's $1 billion bid for rival Healius
December 14, 2023 | ca.finance.yahoo.com
Australian Clinical Labs to withdraw its $1 billion offer to buy Healius
December 14, 2023 | marketwatch.com
Australian Clinical Labs Withdraws Takeover Offer for Healius
December 14, 2023 | reuters.com
Australian Clinical Labs to withdraw its $1 bln offer to buy Healius
November 29, 2023 | theguardian.com
Medical test company’s ‘serious and systemic failures’ led to cyber-attack, watchdog says
November 28, 2023 | afr.com
Sexual health and fertility details leaked in ACL data breach
November 23, 2023 | afr.com
ACL accuses Wylie of hiding links to independent Healius director
November 20, 2023 | afr.com
Dividend drought adds to pain for Healius shareholders
November 20, 2023 | afr.com
Healius preps $200 million equity raising; Barrenjoey on ticket
November 5, 2023 | fool.com.au
This ASX healthcare share just hit a 52-week low, is it time to buy?
November 3, 2023 | msn.com
Live: ASX jumps after Wall Street bounce, as Qantas faces shareholders and ACL faces hacking proceedings
October 30, 2023 | afr.com
Crescent Capital claims stake in clinical trials biz Walski
October 23, 2023 | finance.yahoo.com
What Does Australian Clinical Labs Limited's (ASX:ACL) Share Price Indicate?
August 12, 2023 | finance.yahoo.com
A Look At The Intrinsic Value Of Australian Clinical Labs Limited (ASX:ACL)
See More Headlines
Receive ACL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/25 Dividend
3/27/2024
Today
4/19/2024
Dividend Payable
4/25/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:ACL
CUSIP
N/A
CIK
N/A
Web
www.clinicallabs.com.au
Phone
61 3 9538 6777
Fax
N/A
Employees
5,115
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A$0.08
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.36
Net Income
$15.43 million
Net Margins
2.29%
Pretax Margin
N/A
Return on Equity
9.19%
Return on Assets
5.58%

Debt

Debt-to-Equity Ratio
198.17
Current Ratio
0.66
Quick Ratio
0.53

Sales & Book Value

Annual Sales
$674.03 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.82 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
201,830,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.14
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Ms. Melinda McGrath
    CEO & Executive Director
  • Mr. James Davison
    Chief Financial Officer
  • Mr. Anthony Friedli
    Chief Operating Officer
  • Mr. Sean Jackson
    Chief Information Officer
  • Mr. Joe Geran
    National Marketing Director
  • Associate Prof. Tony Landgren
    National Medical Director & Chief Pathologist
  • Mr. Chris Brownlow
    Chief Executive Officer of New South Wales & Australian Capital Territory
  • Ms. Shae Seymour
    Chief Executive Officer of Western Australia
  • Mr. Eric Swayn
    Chief Executive Officer of South Australia & Northern Territory
  • Ms. Eleanor Padman B.A.
    FCIS, Company Secretary

Key Competitors

View All Competitors

Insiders


ACL Stock Analysis - Frequently Asked Questions

How often does Australian Clinical Labs pay dividends? What is the dividend yield for Australian Clinical Labs?

Australian Clinical Labs announced a Interim dividend on Wednesday, March 27th. Stockholders of record on Thursday, April 25th will be paid a dividend of 0.03 per share on Thursday, April 25th. This represents a dividend yield of 1.1%. The ex-dividend date is Wednesday, March 27th.
Read our dividend analysis for ACL.

Is Australian Clinical Labs a good dividend stock?

Australian Clinical Labs (ASX:ACL) pays an annual dividend of A$0.10 per share and currently has a dividend yield of 3.72%. The dividend payout ratio is 125.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for ACL.

This page (ASX:ACL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press